Tweet
Cell Rep
. 2020 Sep 6;108199.
doi: 10.1016/j.celrep.2020.108199. Online ahead of print.
Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy
Lothar Hennighausen 1 , Hye Kyung Lee 2
Affiliations
- PMID: 32966801
- DOI: 10.1016/j.celrep.2020.108199
Abstract
ACE2 binds the coronavirus SARS-CoV-2 and facilitates its cellular entry. Interferons activate ACE2 expression in pneumocytes, suggesting a critical role of cytokines in SARS-CoV-2 target cells. Viral RNA was detected in breast milk in at least seven studies, raising the possibility that ACE2 is expressed in mammary tissue during lactation. Here, we show that Ace2 expression in mouse mammary tissue is induced during pregnancy and lactation, which coincides with the activation of intronic enhancers. These enhancers are occupied by the prolactin-activated transcription factor STAT5 and additional regulatory factors, including RNA polymerase II. Deletion of Stat5a results in decommissioning of the enhancers and an 83% reduction of Ace2 mRNA. We also demonstrate that Ace2 expression increases during lactation in lung, but not in kidney and intestine. JAK/STAT components are present in a range of SARS-CoV-2 target cells, opening the possibility that cytokines contribute to the viral load and extrapulmonary pathophysiology.
Keywords: ACE2; JAK-STAT pathway; SARS-CoV-2; STAT5; cytokine; enhancer; mammary alveolar epithelium.